P
Paul K. Couchman
Researcher at University of Wollongong
Publications - 39
Citations - 287
Paul K. Couchman is an academic researcher from University of Wollongong. The author has contributed to research in topics: Risk management & Project management. The author has an hindex of 9, co-authored 38 publications receiving 282 citations. Previous affiliations of Paul K. Couchman include Deakin University.
Papers
More filters
Journal ArticleDOI
Rethinking political process in technological change : socio-technical configurations and frames
TL;DR: In this paper, the authors explored the utility of socio-technical configurations and technological frames in understanding change agency through an action research project, which sought a novel form of "socio-technology" transfer, taking ideas and concepts of 'human-centered' manufacturing embodied in team-based cellular manufacture from a European context into three firms in Australia.
Journal ArticleDOI
Facing Up to the Risks in Commercially Focused University-Industry R&D Partnerships.
Liz Fulop,Paul K. Couchman +1 more
TL;DR: In this paper, the authors address three key areas of risks for universities in entering such collaborations, most notably the possibility of financial loss, which has a greater impact than for companies in cross-sector collaborations.
Journal ArticleDOI
Getting Smart: Developing an Action Research Approach to the Integrated Management of Technical and Organizational Innovation
Journal ArticleDOI
Implementing concurrent engineering
TL;DR: In this article, the conditions necessary for firms to implement concurrent engineering successfully are discussed, and a case study of four case studies of the introduction of concurrent engineering in Australian firms is presented.
Journal ArticleDOI
Managing risk in cross-sector R&D collaborations : lessons from an international case study
Paul K. Couchman,Liz Fulop +1 more
TL;DR: In this article, a case study of a successful collaboration involving an Australian Cooperative Research Centre and Ciba Vision, a division of the Swiss multi-national Novartis is presented.